Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 2,495,767 | 26,876,658 | - | - | Class B Common Stock | |
| WM Tech Inc (Class A) | Douglas Francis | Director, Ten Percent Owner | 08 Jun 2022 | 1,818,182 | 4,760,947 | - | 0 | Class A Common Stock | ||
| WM Tech Inc (Class A) | Douglas Francis | Director, Ten Percent Owner | 08 Jun 2022 | 1,818,182 | 12,431,818 | - | 0 | Class V Common Stock | ||
| WM Tech Inc (Class A) | Douglas Francis | Director, Ten Percent Owner | 08 Jun 2022 | 1,818,182 | 12,431,818 | - | - | Post-Merger Class A Units | ||
| Wheels Up Experience Inc (Class A) | Kenneth Dichter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,615,000 | 1,615,000 | - | - | Restricted Stock Units | |
| Wheels Up Experience Inc (Class A) | Kenneth Dichter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,600,000 | 14,753,435 | - | 0 | Class A Common Stock, par value $0.0001 per share | |
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 1,311,980 | 5,570,882 | - | - | Class B Common Stock | |
| Fulgent Genetics Inc | Ming Hsieh | Director, President and CEO, Ten Percent Owner | 08 Jun 2022 | 1,000,000 | 1,000,000 | - | - | Forward sale contract (obligation to sell) | ||
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 818,146 | 6,374,969 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 818,146 | 964,626 | - | - | Class A Common Stock | ||
| Zeta Global Holdings Corp (Class A) | Steven Gerber | President & COO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 723,634 | 3,087,379 | - | 0 | Class A Common Stock | |
| Appian Corp (Class A) | Matthew W. Calkins | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 700,000 | 700,000 | - | - | Employee Stock Option (Right to Buy) | |
| Affirm Holdings Inc (Class A) | Michael Linford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 536,746 | 536,746 | - | - | Stock Option (Right to Buy) | |
| Affirm Holdings Inc (Class A) | Libor Michalek | Director, President, Tech., Risk & Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 536,746 | 536,746 | - | - | Stock Option (Right to Buy) | |
| Zeta Global Holdings Corp (Class A) | Christopher E. Greiner | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 520,005 | 2,168,715 | - | 0 | Class A Common Stock | |
| Brink`s Co. | Douglas A. Pertz | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 400,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Brink`s Co. | Douglas A. Pertz | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.87 per share. | 08 Jun 2022 | 400,000 | 542,351 (1%) | 0% | 29.9 | 11,948,000 | Common Stock |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 375,000 | 891,778 | - | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Jun 2022 | 322,825 | 1,918,298 (2%) | 0% | 6.5 | 2,099,428 | Common Stock |
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 289,382 | 801,200 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 289,382 | 801,200 | - | - | Class B Common Stock | ||
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 289,382 | 321,542 | - | - | Class A Common Stock | ||
| QuantumScape Corp (Class A) | Fritz Prinz | Director | 08 Jun 2022 | 289,382 | 321,542 | - | - | Class A Common Stock | ||
| 1stdibs.com Inc | Thomas Etergino | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 265,000 | 265,000 | - | - | Common Stock | |
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 262,500 | 1,042,500 | - | 0 | Class A Common Stock | |
| Affirm Holdings Inc (Class A) | Katherine Adkins | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 227,085 | 227,085 | - | - | Stock Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 08 Jun 2022 | 209,455 | 1,708,843 (2%) | 0% | 6.2 | 1,294,390 | Common Stock |
| Akebia Therapeutics Inc | David A. Spellman | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 200,000 | 200,000 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | David A. Spellman | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 200,000 | 328,599 (0%) | 0% | 0 | Common Stock | |
| American Airlines Grp Inc | W. Douglas Parker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 185,758 | 2,772,714 (0%) | 0% | 0 | Common Stock | |
| 1stdibs.com Inc | Thomas Etergino | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | |
| Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 128,493 | 0 (0%) | 0% | - | Common Stock | |
| RxSight Inc | William J. Link | Director | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 126,979 | 380,937 | - | 0 | Common Stock | |
| Renovaro Biosciences Inc | Rene Sindlev | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 125,000 | 0 (0%) | 0% | - | Common Stock | |
| RPC Inc | Gary W. Rollins | Director, Ten Percent Owner | 08 Jun 2022 | 124,687 | 3,806,042 (1%) | 0% | 9.4 | 1,176,846 | Common Stock, $.10 Par Value | |
| Affirm Holdings Inc (Class A) | Katherine Adkins | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 117,873 | 117,873 | - | - | Restricted Stock Units | |
| Senti Biosciences Inc | David R. Epstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 112,519 | 123,252 | - | 0 | Common Stock | |
| Senti Biosciences Inc | David R. Epstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 112,519 | 0 | - | - | Class B Common Stock | |
| Brink`s Co. | Douglas A. Pertz | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.90 per share. | 08 Jun 2022 | 109,326 | 433,025 (0%) | 0% | 61.9 | 6,767,279 | Common Stock |
| Hallador Energy Co | Charles Wesley | Director | 08 Jun 2022 | 108,202 | 199,472 (0%) | 0% | 4.6 | 500,001 | Common Stock | |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 08 Jun 2022 | 100,000 | 4,270,640 | - | 3.3 | 329,000 | Class A Common Stock |
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 08 Jun 2022 | 100,000 | 920,800 | - | 41.6 | 4,155,900 | Class A Ordinary Shares |
| Hippo Holdings Inc | Hugh R. Frater | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 127,656 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Sandra S. Wijnberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 127,656 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Noah Knauf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 294,869 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Lori Dickerson Fouche | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 127,656 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Amy Errett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 127,656 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Eric Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 127,656 | - | 0 | Common Stock | |
| Hippo Holdings Inc | Sam Landman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 97,656 | 139,469 | - | 0 | Common Stock | |
| QuantumScape Corp (Class A) | Fritz Prinz | Director | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 08 Jun 2022 | 93,360 | 146,480 | - | 12.0 | 1,121,935 | Class A Common Stock |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 91,743 | 91,743 | - | - | Warrant (Right to Buy) | |
| Aquestive Therapeutics Inc | Daniel Barber | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 91,743 | 193,702 (0%) | 0% | 1.0 | 88,073 | Common Stock |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 85,551 | 370,402 (3%) | 0% | 0.1 | 11,122 | CLASS A COMMON STOCK | |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 85,551 | 284,851 (2%) | 0% | 0.8 | 70,152 | CLASS A COMMON STOCK | |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 85,551 | 246,290 | - | - | STOCK OPTION | ||
| Brink`s Co. | Douglas A. Pertz | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.90 per share. | 08 Jun 2022 | 83,696 | 348,540 (0%) | 0% | 61.9 | 5,180,782 | Common Stock |
| Brink`s Co. | Douglas A. Pertz | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.90 per share. | 08 Jun 2022 | 81,447 | 267,882 (0%) | 0% | 61.9 | 5,041,569 | Common Stock |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 71,851 | 378,951 (0%) | 0% | 0.0 | 1,926 | Ords |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 68,310 | 447,261 (0%) | 0% | 0.0 | 1,940 | Ords |
| fuboTV Inc | Daniel V. Leff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 66,061 | 66,061 | - | - | Restricted Stock Units | |
| fuboTV Inc | Laura Diane Onopchenko | Director | 08 Jun 2022 | 66,061 | 66,061 | - | - | Restricted Stock Units | ||
| fuboTV Inc | Ignacio Figueras | Director, Consultant | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 66,061 | 66,061 | - | - | Restricted Stock Units | |
| fuboTV Inc | Par-Jorgen Parson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 66,061 | 66,061 | - | - | Restricted Stock Units | |
| Lyell Immunopharma Inc | Catherine J. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Robert Taylor Nelsen | Director, Ten Percent Owner | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | ||
| Lyell Immunopharma Inc | Otis W. Brawley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Lynn Seely | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | William J. Rieflin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Hans Edgar Bishop | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Elizabeth G. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
| SouthState Corp | Robert R. Hill | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 64,668 | 132,285 (0%) | 0% | 0 | Common Stock | |
| Elastic N.V | Carolyn Herzog | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 60,483 | 60,483 (0%) | 0% | 0 | Ordinary Shares | |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 55,991 | 668,295 (0%) | 0% | 0.0 | 1,500 | Ords |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 55,555 | 557,560 (0%) | 0% | 0.0 | 1,500 | Ords |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 54,744 | 502,005 (0%) | 0% | 0.0 | 1,500 | Ords |
| OKYO Pharma Ltd - Ordinary Shares - New | Willy Jules Simon | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 08 Jun 2022 | 54,744 | 612,304 (0%) | 0% | 0.0 | 1,500 | Ords |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 53,898 | 0 | - | - | Stock Options (Right to Buy) | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.94 per share. | 08 Jun 2022 | 53,898 | 1,786,583 (0%) | 0% | 17.9 | 966,930 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Sale of securities on an exchange or to another person at price $ 15.60 per share. | 08 Jun 2022 | 50,000 | 972,855 | - | 15.6 | 779,825 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 50,000 | 1,291,174 | - | - | Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Michael D. Hughes | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 08 Jun 2022 | 50,000 | 1,022,855 | - | 0.6 | 28,000 | Common Stock |
| Byline Bancorp Inc | Lindsay Y. Corby | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 48,748 | 0 | - | - | Common Stock | |
| Byline Bancorp Inc | Lindsay Y. Corby | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.18 per share. | 08 Jun 2022 | 48,748 | 83,815 (0%) | 0% | 11.2 | 545,003 | Common Stock |
| Eastside Distilling Inc | Elizabeth Ann Levy-Navarro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 48,551 | 48,551 | - | - | Restricted Stock Units | |
| Eastside Distilling Inc | Elizabeth Ann Levy-Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 48,551 | 78,421 (0%) | 0% | 0 | Common Stock | |
| Eastside Distilling Inc | Elizabeth Ann Levy-Navarro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 48,551 | 0 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Lance West | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 47,619 | 47,619 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Brian L. Libman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 47,619 | 47,619 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Norma C. Corio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 47,619 | 47,619 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Tyson A. Pratcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 47,619 | 47,619 | - | - | Restricted Stock Units | |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 46,290 | 331,141 (2%) | 0% | 0.1 | 6,018 | CLASS A COMMON STOCK | |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 46,290 | 284,851 (2%) | 0% | 0.8 | 35,643 | CLASS A COMMON STOCK | |
| Boxlight Corp (Class A) | James Mark Elliott | Director | 08 Jun 2022 | 46,290 | 200,000 | - | - | STOCK OPTION | ||
| Aquestive Therapeutics Inc | A. Mark Schobel | Chief Innovation/Tech Officer | 08 Jun 2022 | 45,871 | 45,871 | - | - | Warrant (Right to Buy) | ||
| Aquestive Therapeutics Inc | A. Mark Schobel | Chief Innovation/Tech Officer | 08 Jun 2022 | 45,871 | 882,871 (2%) | 0% | 1.0 | 44,036 | Common Stock | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 45,560 | 0 | - | - | Stock Options (Right to Buy) | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.68 per share. | 08 Jun 2022 | 45,560 | 1,778,245 (0%) | 0% | 18.7 | 851,061 | Common Stock |
| Angi Inc (Class A) | Thomas R. Evans | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Jeremy G. Philips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Alesia J. Haas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Glenn H. Schiffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Suzy Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Sandra Hurse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 45,454 | 45,454 | - | - | Restricted Stock Units | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 08 Jun 2022 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 08 Jun 2022 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 4,347,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 4,387,155 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Alexis A. Borisy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Lesley Ann Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Aaron I. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Malte Peters | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | Mace Rothenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Autonation Inc | Edward S. Lampert | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 121.78 per share. | 08 Jun 2022 | 38,153 | 8,225,959 (9%) | 0% | 121.8 | 4,646,158 | Common Stock, par value $0.01 per share |
| Elastic N.V | Carolyn Herzog | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 37,620 | 37,620 | - | - | Employee Stock Option (right to buy) | |
| ePlus Inc | Mark P. Marron | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 37,587 | 130,479 (0%) | 0% | 0 | Common Stock | |
| Array Tech Inc | Kevin George Hostetler | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 13.33 per share. | 08 Jun 2022 | 37,500 | 144,883 | - | 13.3 | 499,875 | Common Stock, par value $0.001 per share |
| Williams Companies | Debbie L. Cowan | SVP & Chief HR Officer | Sale of securities on an exchange or to another person at price $ 37.75 per share. | 08 Jun 2022 | 35,228 | 63,891 (0%) | 0% | 37.8 | 1,329,857 | Common Stock |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Sale of securities on an exchange or to another person at price $ 22.70 per share. | 08 Jun 2022 | 35,218 | 1,743,027 (0%) | 0% | 22.7 | 799,449 | Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 299.03 per share. | 08 Jun 2022 | 35,000 | 204,744 (0%) | 0% | 299.0 | 10,466,050 | Class A Common Stock |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 35,000 | 74,181 | - | - | Employee Stock Option (Right to Buy) | |
| MongoDB Inc (Class A) | Dev C. Ittycheria | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.50 per share. | 08 Jun 2022 | 35,000 | 239,744 (0%) | 0% | 6.5 | 227,500 | Class A Common Stock |
| LyondellBasell (Class A) | Michael C. McMurray | EVP & CFO | 08 Jun 2022 | 33,880 | 39,612 (0%) | 0% | 110.9 | 3,758,485 | Class A Ordinary Shares | |
| LyondellBasell (Class A) | Michael C. McMurray | EVP & CFO | 08 Jun 2022 | 33,880 | 16,940 | - | - | Stock Options (Right to Buy) | ||
| LyondellBasell (Class A) | Michael C. McMurray | EVP & CFO | 08 Jun 2022 | 33,880 | 73,492 (0%) | 0% | 78.2 | 2,647,722 | Class A Ordinary Shares | |
| International Money Express Inc | John Rincon | Director | Sale of securities on an exchange or to another person at price $ 20.21 per share. | 08 Jun 2022 | 33,486 | 46,945 (0%) | 0% | 20.2 | 676,913 | Common Stock |
| Palantir | Alexander Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,679 | 1,972,305 | - | 0 | Class A Common Stock | |
| Palantir | Alexandra Schiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,679 | 192,361 | - | 0 | Class A Common Stock | |
| Palantir | Lauren Elaina Friedman Stat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,679 | 51,842 | - | 0 | Class A Common Stock | |
| Porch Group Inc Ordinary | Regi Vengalil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 32,166 | 39,317 | - | 0 | Common Stock | |
| Shift4 Payments Inc (Class A) | Jordan Frankel | GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.89 per share. | 08 Jun 2022 | 31,410 | 242,570 | - | 46.9 | 1,472,815 | Class A Common Stock |
| QuantumScape Corp (Class A) | Fritz Prinz | Director | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 08 Jun 2022 | 31,120 | 32,160 | - | 12.0 | 373,978 | Class A Common Stock |
| QuantumScape Corp (Class A) | Fritz Prinz | Director | Sale of securities on an exchange or to another person at price $ 12.02 per share. | 08 Jun 2022 | 31,120 | 32,160 | - | 12.0 | 373,978 | Class A Common Stock |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 30,770 | 30,770 | - | - | Class B Common Stock | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 08 Jun 2022 | 30,770 | 0 | - | - | Class B Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 30,770 | 1,446,150 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 08 Jun 2022 | 30,770 | 464,313 (0%) | 0% | 0 | Class A Common Stock | ||
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.48 per share. | 08 Jun 2022 | 30,700 | 78,901 (0%) | 0% | 78.5 | 2,409,183 | Common Stock |
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 30,700 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Sale of securities on an exchange or to another person at price $ 110.22 per share. | 08 Jun 2022 | 30,700 | 48,201 (0%) | 0% | 110.2 | 3,383,686 | Common Stock |
| Byline Bancorp Inc | Lindsay Y. Corby | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.71 per share. | 08 Jun 2022 | 30,154 | 53,661 (0%) | 0% | 24.7 | 745,105 | Common Stock |
| Xometry Inc (Class A) | Kathy Mayerhofer | Chief Sales Officer | Sale of securities on an exchange or to another person at price $ 35.47 per share. | 08 Jun 2022 | 30,000 | 57,723 | - | 35.5 | 1,064,070 | Class A Common Stock |
| SouthState Corp | Robert R. Hill | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.21 per share. | 08 Jun 2022 | 29,974 | 102,311 (0%) | 0% | 80.2 | 2,404,215 | Common Stock |
| Absci Corp | Karen K. McGinnis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 28,700 | 28,700 | - | - | Stock Option (right to buy) | |
| Absci Corp | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 28,700 | 28,700 | - | - | Stock Option (right to buy) | |
| Absci Corp | Zachariah Jonasson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 28,700 | 28,700 | - | - | Stock Option (right to buy) | |
| Stem Inc (Class A) | John Carrington | Director, CEO and Director | Sale of securities on an exchange or to another person at price $ 9.34 per share. | 08 Jun 2022 | 28,570 | 412,113 | - | 9.3 | 266,938 | Common Stock, Par Value $0.0001 Per Share |
| Stem Inc (Class A) | John Carrington | Director, CEO and Director | Sale of securities on an exchange or to another person at price $ 8.99 per share. | 08 Jun 2022 | 28,570 | 383,543 | - | 9.0 | 256,901 | Common Stock, Par Value $0.0001 Per Share |
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 28,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Sale of securities on an exchange or to another person at price $ 110.20 per share. | 08 Jun 2022 | 28,400 | 48,201 (0%) | 0% | 110.2 | 3,129,765 | Common Stock |
| Phillips 66 | Timothy D. Roberts | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.97 per share. | 08 Jun 2022 | 28,400 | 76,601 (0%) | 0% | 86.0 | 2,441,639 | Common Stock |
| Aeglea BioTherapeutics Inc | Michael Conick Hanley | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 08 Jun 2022 | 28,200 | 36,200 (0%) | 0% | 0.7 | 20,022 | Common Stock |
| Global Partners LP - Unit | Mark A. Romaine | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,613 | 52,978 | - | - | Phantom Units | |
| Eastside Distilling Inc | Elizabeth Ann Levy-Navarro | Director | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 08 Jun 2022 | 27,030 | 29,870 (0%) | 0% | 0.7 | 19,716 | Common Stock |
| Praxis Precision Medicines Inc | Marcio Souza | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 08 Jun 2022 | 27,000 | 189,184 | - | 1.8 | 49,888 | Common Stock |
| Quince Therapeutics Inc | Una S. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Christopher J. Senner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Porch Group Inc Ordinary | Alan R. Pickerill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 26,542 | 38,396 | - | 0 | Common Stock | |
| Zeta Global Holdings Corp (Class A) | David A. Steinberg | Director, Chief Executive Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 26,424 | 184,932 | - | 0 | Class A Common Stock | |
| 3D Systems Corp | Charles W. Hull | Director, EVP & CTO (Regenerative Med) | Sale of securities on an exchange or to another person at price $ 10.95 per share. | 08 Jun 2022 | 26,386 | 51,634 (0%) | 0% | 10.9 | 288,803 | Common Stock |
| Porch Group Inc Ordinary | Rachel Lam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 26,350 | 35,980 | - | 0 | Common Stock | |
| Porch Group Inc Ordinary | Maurice Tulloch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,707 | 30,621 | - | 0 | Common Stock | |
| American Airlines Grp Inc | John T. Cahill | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 25,552 | 25,552 (0%) | 0% | 0 | Common Stock | |
| American Airlines Grp Inc | John T. Cahill | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 25,552 | 0 (0%) | 0% | 0 | Common Stock | |
| PLAYSTUDIOS Inc (Class A) | James Joseph Murren | Director | 08 Jun 2022 | 25,510 | 25,510 | - | 0 | Class A Common Stock | ||
| PLAYSTUDIOS Inc (Class A) | Jason Krikorian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,510 | 25,510 | - | 0 | Class A Common Stock | |
| PLAYSTUDIOS Inc (Class A) | Hyman Joseph Horowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,510 | 25,510 | - | 0 | Class A Common Stock | |
| PLAYSTUDIOS Inc (Class A) | Steve Zanella | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,510 | 25,510 | - | 0 | Class A Common Stock | |
| Global Partners LP - Unit | Mark A. Romaine | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 25,365 | 102,023 (0%) | 0% | 0 | Common units representing limited partner interests | |
| Global Partners LP - Unit | Mark A. Romaine | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 25,365 | 27,613 | - | - | Phantom Units | |
| Brilliant Earth Grp Inc (Class A) | Beth J. Kaplan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,134 | 31,134 | - | 0 | Class A Common Stock | |
| Brilliant Earth Grp Inc (Class A) | Jennifer N. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,134 | 30,134 | - | 0 | Class A Common Stock | |
| Brilliant Earth Grp Inc (Class A) | Ian M. Bickley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,134 | 75,134 | - | 0 | Class A Common Stock | |
| Brilliant Earth Grp Inc (Class A) | Attica A. Jaques | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,134 | 25,434 | - | 0 | Class A Common Stock | |
| Praxis Precision Medicines Inc | Dean Jonathan Mitchell | Director | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | 1.8 | 45,188 | Common Stock |
| Xeris Biopharma Holdings Inc | Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | John Schmid | Director | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Xeris Biopharma Holdings Inc | Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharma Inc | David Michael Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 24,871 | 108,330 | - | 0 | Common Stock | |
| Cars.com | Scott E. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 24,567 | 142,222 (0%) | 0% | 0 | Common Stock | |
| Autonation Inc | Edward S. Lampert | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 120.31 per share. | 08 Jun 2022 | 23,287 | 8,182,070 (9%) | 0% | 120.3 | 2,801,727 | Common Stock, par value $0.01 per share |
| Porch Group Inc Ordinary | Sean Kell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 23,136 | 33,956 | - | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Bahram Akradi | Director, Founder & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 08 Jun 2022 | 23,072 | 11,255,025 | - | 13.0 | 298,808 | Common Stock |
| ePlus Inc | Elaine D. Marion | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 23,065 | 77,781 (0%) | 0% | 0 | Common Stock | |
| ePlus Inc | Darren S. Raiguel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 23,065 | 77,781 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | John W. Higuchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 307,490 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | Richard Dana Ono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 136,000 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | Jeffrey A Fink | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 136,000 | - | - | Common Stock (Right to Buy) | |
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Bluelinx Hldgs Inc | Kelly C. Janzen | SVP, CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 21,960 | 57,304 (0%) | 0% | - | Common Stock | |
| Bluelinx Hldgs Inc | Kelly C. Janzen | SVP, CFO AND TREASURER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 21,960 | 21,891 | - | - | Restricted Stock Units | |
| Zentalis Pharma Inc | Enoch Kariuki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 21,817 | 21,817 | - | 0 | Common Stock | |
| Columbus Mckinnon Corp | Kurt F. Wozniak | Former Officer | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 08 Jun 2022 | 21,216 | 4,509 (0%) | 0% | 34.1 | 723,041 | Common Stock |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 20,850 | 2,401,250 | - | - | Employee Stock Option (Right to Buy) | |
| Etsy Inc | Joshua G. Silverman | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.62 per share. | 08 Jun 2022 | 20,850 | 123,557 (0%) | 0% | 10.6 | 221,427 | Common Stock |
| Autonation Inc | Edward S. Lampert | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 123.98 per share. | 08 Jun 2022 | 20,602 | 8,205,357 (9%) | 0% | 124.0 | 2,554,331 | Common Stock, par value $0.01 per share |
| 1stdibs.com Inc | Ross A. Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 20,124 | 141,156 | - | - | Common Stock | |
| Akebia Therapeutics Inc | Adrian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Cynthia Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Myles Wolf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Akebia Therapeutics Inc | Ron Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,100 | 20,100 | - | - | Stock Option (Right to buy) | |
| Accel Entertainment Inc (Class A1) | Michael Marino | Chief Commerical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 20,019 | 220,204 | - | - | Restricted Stock Units (RSU) | |
| Accel Entertainment Inc (Class A1) | Michael Marino | Chief Commerical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 20,019 | 128,236 (7%) | 1% | 0 | Class A-1 Common Stock | |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Sale of securities on an exchange or to another person at price $ 15.63 per share. | 08 Jun 2022 | 20,000 | 23,985 | - | 15.6 | 312,558 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 08 Jun 2022 | 20,000 | 30,599 | - | 0.8 | 15,200 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 08 Jun 2022 | 20,000 | 10,599 | - | 15.6 | 312,794 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Bruce R. Chizen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 378,640 | - | - | Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Lawrence Lee | See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 08 Jun 2022 | 20,000 | 301,513 | - | 15.6 | 312,270 | Common Stock |
| Robinhood Markets Inc (Class A) | Jason Warnick | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 08 Jun 2022 | 20,000 | 426,407 | - | 8.5 | 170,534 | Class A Common Stock |
| Interactive Brokers Grp Inc (Class A) | Thomas Peterffy | Director, Chairman | Sale of securities on an exchange or to another person at price $ 58.29 per share. | 08 Jun 2022 | 20,000 | 2,267,511 (2%) | 0% | 58.3 | 1,165,800 | Class A common stock |
| Rhythm Pharma Inc | Christophe R. Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Edward T. Mathers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | David W.J. McGirr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Jennifer L. Good | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Camille L. Bedrosian | Director | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | ||
| Rhythm Pharma Inc | Lynn A. Tetrault | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Stuart A. Arbuckle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Halliburton | Joe D. Rainey | Pres., Eastern Hemisphere | Sale of securities on an exchange or to another person at price $ 42.73 per share. | 08 Jun 2022 | 20,000 | 310,013 (0%) | 0% | 42.7 | 854,600 | Common Stock |
| Flywire Corp | Jo Natauri | Director | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 08 Jun 2022 | 19,898 | 1,538,574 | - | 19.0 | 378,659 | Voting Common Stock |
| Repay Holdings Corp (Class A) | Peter J. Kight | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 19,607 | 1,349,620 (3%) | 0% | 0 | Class A Common Stock | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 08 Jun 2022 | 19,600 | 1,766,983 (0%) | 0% | 22.7 | 445,116 | Common Stock |
| Shift4 Payments Inc (Class A) | David Taylor Lauber | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.89 per share. | 08 Jun 2022 | 19,431 | 175,989 | - | 46.9 | 911,120 | Class A Common Stock |
| MFA Fin Inc | Laurie S. Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 19,386 | 70,085 | - | - | Restricted Stock Units | |
| Star Equity Holdings Inc | Jeffrey E. Eberwein | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 08 Jun 2022 | 19,025 | 2,337,327 (114%) | 0% | 1.1 | 20,167 | Common Stock |
| KVH Ind Inc | Brent C. Bruun | Interim CEO | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 18,700 | 155,828 (0%) | 0% | 0 | Common Stock | |
| Finance of America Companies Inc | Lance West | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 0 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Lance West | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 18,691 | - | - | Class A Common Stock | |
| Finance of America Companies Inc | Brian L. Libman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 103,625 | - | - | Class A Common Stock | |
| Finance of America Companies Inc | Brian L. Libman | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 0 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Norma C. Corio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 0 | - | - | Restricted Stock Units | |
| Finance of America Companies Inc | Norma C. Corio | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 18,691 | - | - | Class A Common Stock | |
| Finance of America Companies Inc | Tyson A. Pratcher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 18,691 | - | - | Class A Common Stock | |
| Finance of America Companies Inc | Tyson A. Pratcher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 18,691 | 0 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Gregg Winiarski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 17,793 | 17,793 (0%) | 0% | 0 | Class A Common Stock, par value $0.001 | |
| Angi Inc (Class A) | Gregg Winiarski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 17,793 | 0 | - | - | Restricted Stock Units | |
| Alkermes PLC | Christopher I. Wright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,773 | 17,773 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Figs Inc (Class A) | Michael J. Soenen | Director | 08 Jun 2022 | 17,606 | 24,425 | - | 0 | Class A Common Stock | ||
| Figs Inc (Class A) | Alan G. Lafley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,606 | 18,726 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Jeffrey A. Wilke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,606 | 136,339 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Sheila Antrum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,606 | 24,425 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | John Martin Willhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,606 | 3,171,857 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Kenneth Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,606 | 70,467 | - | 0 | Class A Common Stock | |
| Tectonic Therapeutic Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Phillip B. Donenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Phillip B. Donenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Bruce Booth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Gail M. Farfel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Philip J. Vickers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Christopher Paige | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | Vicki L. Sato | Director | Sale of securities on an exchange or to another person at price $ 25.82 per share. | 08 Jun 2022 | 17,415 | 1,489,079 (1%) | 0% | 25.8 | 449,721 | Common Stock |
| Life Time Grp Holdings Inc | Bahram Akradi | Director, Founder & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 17,348 | 938,096 | - | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Bahram Akradi | Director, Founder & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Jun 2022 | 17,348 | 11,231,953 | - | 0 | Common Stock | |
| Cars.com | Jill A. Greenthal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 88,390 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Thomas Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 80,741 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Jerri L. DeVard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 75,828 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Michael Joseph Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 72,951 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Donald A. McGovern | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 82,231 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Greg Revelle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 80,828 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Bryan J. Wiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 78,542 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Bala Subramanian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 71,909 (0%) | 0% | 0 | Common Stock | |
| Cars.com | Jenell R. Ross | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,342 | 31,081 (0%) | 0% | 0 | Common Stock | |
| SoFi Tech Inc | Anthony J. Noto | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.65 per share. | 08 Jun 2022 | 16,907 | 3,385,921 | - | 6.6 | 112,416 | Common Stock |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 85.97 per share. | 08 Jun 2022 | 16,491 | 440,018 (0%) | 0% | 86.0 | 1,417,731 | Class A Common Stock |
| LegalZoom.com Inc | John F. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,213 | 30,497 | - | 0 | Common Stock (RSUs) | |
| LegalZoom.com Inc | Sivan Whiteley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,213 | 32,459 | - | 0 | Common Stock (RSUs) | |
| LegalZoom.com Inc | Elizabeth Hamren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,213 | 26,159 | - | 0 | Common Stock (RSUs) | |
| Nkarta Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Laura Shawver | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Simeon J. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Michael Dybbs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Ali Behbahani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Tiba Aynechi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Fouad Azzam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Zachary Scheiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 149.94 per share. | 08 Jun 2022 | 15,972 | 5,421,974 (1%) | 0% | 149.9 | 2,394,842 | Common Stock |
| Airbnb | David E. Stephenson | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 08 Jun 2022 | 15,971 | 201,835 | - | 125 | 1,996,375 | Class A Common Stock |
| Veracyte Inc | Kevin K. Gordon | Director | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 08 Jun 2022 | 15,000 | 8,720 (0%) | 0% | 18.5 | 277,502 | Common Stock |
| Veracyte Inc | Kevin K. Gordon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Kevin K. Gordon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.39 per share. | 08 Jun 2022 | 15,000 | 23,720 (0%) | 0% | 7.4 | 110,850 | Common Stock |
| Xeris Biopharma Holdings Inc | Jeffrey W. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 65,378 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | John H. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 493,312 (1%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | John Schmid | Director | 08 Jun 2022 | 15,000 | 20,659 (0%) | 0% | 0 | Common Stock | ||
| Xeris Biopharma Holdings Inc | Garheng Kong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 65,170 (0%) | 0% | 0 | Common Stock | |
| Xeris Biopharma Holdings Inc | B. J. Bormann | Director | Grant, award, or other acquisition of securities at price $ 2.10 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 2.1 | 31,500 | Common Stock |
| Xeris Biopharma Holdings Inc | Dawn Halkuff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| KVH Ind Inc | Robert J. Balog | Chief Technology Officer | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 14,960 | 93,772 (0%) | 0% | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Bahram Akradi | Director, Founder & CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.48 per share. | 08 Jun 2022 | 14,814 | 11,269,839 | - | 13.5 | 199,716 | Common Stock |
| DoubleVerify Holdings Inc | Laura Desmond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 14,570 | 655,811 | - | - | Options (Rights to Buy) | |
| DoubleVerify Holdings Inc | Laura Desmond | Director | Sale of securities on an exchange or to another person at price $ 22.81 per share. | 08 Jun 2022 | 14,570 | 179,071 | - | 22.8 | 332,401 | Common Stock |
| DoubleVerify Holdings Inc | Laura Desmond | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.01 per share. | 08 Jun 2022 | 14,570 | 193,641 | - | 2.0 | 29,286 | Common Stock |
| KVH Ind Inc | Roger A. Kuebel | CFO | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 14,321 | 14,321 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.19 per share. | 08 Jun 2022 | 14,000 | 5,437,946 (1%) | 0% | 148.2 | 2,074,660 | Common Stock |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 08 Jun 2022 | 13,925 | 1,753,058 (0%) | 0% | 22.7 | 316,376 | Common Stock |
| Global Partners LP - Unit | Gregory B. Hanson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,807 | 16,195 | - | - | Phantom Units | |
| Aquestive Therapeutics Inc | Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Jun 2022 | 13,761 | 38,761 (0%) | 0% | 1.0 | 13,211 | Common Stock |
| Aquestive Therapeutics Inc | Lori J. Braender | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Jun 2022 | 13,761 | 13,761 | - | - | Warrant (Right to Buy) | |
| KVH Ind Inc | Felise B. Feingold | SVP General Counsel | Other type of transaction at price $ 0.00 per share. | 08 Jun 2022 | 13,731 | 67,541 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Adrian Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 104,800 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | LeAnne M. Zumwalt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 13,700 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Steven C. Gilman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 57,130 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Michael W. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 66,029 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Cynthia Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 65,233 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Myles Wolf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 37,681 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc | Ron Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,700 | 13,700 (0%) | 0% | 0 | Common Stock | |
| Repay Holdings Corp (Class A) | Richard E. Thornburgh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,333 | 61,490 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Paul R. Garcia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,333 | 106,190 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | William I. Jacobs | Director | 08 Jun 2022 | 13,333 | 40,390 (0%) | 0% | 0 | Class A Common Stock | ||
| Repay Holdings Corp (Class A) | Robert Hartheimer | Director | 08 Jun 2022 | 13,333 | 57,264 (0%) | 0% | 0 | Class A Common Stock | ||
| Repay Holdings Corp (Class A) | Maryann B. Goebel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,333 | 40,390 (0%) | 0% | 0 | Class A Common Stock | |
| Repay Holdings Corp (Class A) | Emnet Rios | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 13,333 | 22,637 (0%) | 0% | 0 | Class A Common Stock | |
| SouthState Corp | Daniel Bockhorst | Chief Credit Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 13,130 | 34,175 (0%) | 0% | 0 | Common Stock | |
| SouthState Corp | Renee Brooks | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 13,130 | 39,232 (0%) | 0% | 0 | Common Stock | |
| SouthState Corp | Greg A. Lapointe | Chief Banking Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 13,130 | 31,070 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 136.71 per share. | 08 Jun 2022 | 12,629 | 5,430,518 (1%) | 0% | 136.7 | 1,726,511 | Common Stock |
| Abercrombie & Fitch Co. (Class A) | Terry Lee Burman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,608 | 18,633 | - | - | Restricted Stock Unit | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 12,566 | 175,606 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 08 Jun 2022 | 12,566 | 3,000 | - | 6.6 | 83,362 | Common Stock |
| Edgewise Therapeutics Inc | John R. Moore | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 08 Jun 2022 | 12,566 | 15,566 | - | 0.7 | 8,922 | Common Stock |
| National Bank Holdings Corp (Class A) | G. Timothy Laney | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 08 Jun 2022 | 12,500 | 298,708 (0%) | 0% | 40.6 | 507,500 | Common Stock |
| Viridian Therapeutics Inc | Arlene M. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Jennifer K. Moses | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Peter Harwin | Director | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | ||
| Viridian Therapeutics Inc | Tomas Kiselak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| First Horizon Corp | Daryl G. Byrd | Director, Executive Chairman of Board | Sale of securities on an exchange or to another person at price $ 22.73 per share. | 08 Jun 2022 | 12,314 | 1,740,434 (0%) | 0% | 22.7 | 279,897 | Common Stock |
| Rave Restaurant Group Inc | Mark E. Schwarz | Director, Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 08 Jun 2022 | 12,252 | 3,092,125 (20%) | 0% | 1.0 | 12,007 | Common Stock |
| Interactive Brokers Grp Inc (Class A) | Thomas Peterffy | Director, Chairman | Sale of securities on an exchange or to another person at price $ 58.79 per share. | 08 Jun 2022 | 12,035 | 2,295,476 (2%) | 0% | 58.8 | 707,538 | Class A common stock |
| Bluelinx Hldgs Inc | Shyam K. Reddy | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 14,484 (0%) | 0% | - | Common Stock | |
| Bluelinx Hldgs Inc | Shyam K. Reddy | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 12,000 | - | - | Restricted Stock Units | |
| Apellis Pharma Inc | Pascal Deschatelets | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 12,000 | 352,999 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharma Inc | Pascal Deschatelets | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 08 Jun 2022 | 12,000 | 903,775 (1%) | 0% | 2.7 | 32,040 | Common Stock |
| Apellis Pharma Inc | Pascal Deschatelets | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 44.09 per share. | 08 Jun 2022 | 12,000 | 891,775 (1%) | 0% | 44.1 | 529,080 | Common Stock |
| Absci Corp | Joseph Sirosh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,958 | 11,958 | - | - | Stock Option (right to buy) | |
| Ceco Environmental Corp | David B. Liner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 100,080 (0%) | 0% | 0 | Common Stock | |
| Ceco Environmental Corp | Jason Louis Dezwirek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 1,513,554 (4%) | 0% | 0 | Common Stock | |
| Ceco Environmental Corp | Claudio A. Mannarino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 83,284 (0%) | 0% | 0 | Common Stock | |
| Ceco Environmental Corp | Valerie Gentile Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 74,446 (0%) | 0% | 0 | Common Stock | |
| Ceco Environmental Corp | Richard F. Wallman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 112,822 (0%) | 0% | 0 | Common Stock | |
| Ceco Environmental Corp | Munish Nanda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,941 | 52,938 (0%) | 0% | 0 | Common Stock | |
| Sight Sciences Inc | Donald J. Zurbay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Mack H. Hicks | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Erica J. Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Staffan Encrantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Valeska Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,940 | 11,940 | - | - | Restricted Stock Units | |
| Bluelinx Hldgs Inc | Kelly C. Janzen | SVP, CFO AND TREASURER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.50 per share. | 08 Jun 2022 | 11,442 | 45,862 (0%) | 0% | 84.5 | 966,849 | Common Stock |
| Palantir | Alexander Moore | Director | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 08 Jun 2022 | 11,377 | 1,960,928 | - | 8.9 | 101,102 | Class A Common Stock |
| Luxfer Holdings PLC | Patrick K. Mullen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,334 | 11,334 | - | - | Restricted Stock Units | |
| Global Partners LP - Unit | Mark A. Romaine | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.78 per share. | 08 Jun 2022 | 11,248 | 90,775 (0%) | 0% | 27.8 | 312,469 | Common units representing limited partner interests |
| MFA Fin Inc | Lisa Polsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,973 | 35,116 | - | - | Restricted Stock Units | |
| MFA Fin Inc | Robin Josephs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,973 | 56,275 | - | - | Restricted Stock Units | |
| MFA Fin Inc | Sheila A. Stamps | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,973 | 10,973 | - | - | Restricted Stock Units | |
| MFA Fin Inc | Francis J. Oelerich | Director | 08 Jun 2022 | 10,973 | 40,267 | - | - | Restricted Stock Units | ||
| MFA Fin Inc | Richard C. Wald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,973 | 35,116 | - | - | Restricted Stock Units | |
| SEACOR Marine Holdings Inc | Alfredo Miguel Bejos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,885 | 110,473 (0%) | 0% | 0 | Common Stock | |
| Yext Inc | Julie G. Richardson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Julie G. Richardson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 71,409 (0%) | 0% | - | Common Stock | |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 16,879 (0%) | 0% | - | Common Stock | |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Seth H. Waugh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Seth H. Waugh | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 32,486 (0%) | 0% | - | Common Stock | |
| Yext Inc | Tamar Yehoshua | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 77,258 (0%) | 0% | - | Common Stock | |
| Yext Inc | Tamar Yehoshua | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Jesse Lipson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Jesse Lipson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,877 | 355,254 (0%) | 0% | - | Common Stock | |
| 1stdibs.com Inc | Melanie F. Goins | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,662 | 10,662 | - | - | Common Stock | |
| 1stdibs.com Inc | Ross A. Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.18 per share. | 08 Jun 2022 | 10,493 | 129,449 | - | 3.2 | 33,368 | Common Stock |
| 1stdibs.com Inc | Ross A. Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,493 | 0 | - | - | Employee Stock Option (right to buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 137.58 per share. | 08 Jun 2022 | 10,458 | 5,420,060 (1%) | 0% | 137.6 | 1,438,812 | Common Stock |
| IBM | Arvind Krishna | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,091 | 20,182 | - | - | Rst. Stock Unit | |
| IBM | Arvind Krishna | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,091 | 188,867 (0%) | 0% | 0 | Common Stock | |
| 1stdibs.com Inc | Ross A. Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,062 | 150,938 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Ross A. Paul | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2022 | 10,062 | 70,438 | - | - | Restricted Stock Units | |
| Certara Inc | Patrick F Smith | PRESIDENT, INTEGRATED DRUG DEV | 08 Jun 2022 | 10,000 | 88,490 | - | 19.2 | 191,600 | Common Stock | |
| Crexendo Inc | Steven G. Mihaylo | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.97 per share. | 08 Jun 2022 | 10,000 | 11,104,588 | - | 3.0 | 29,700 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.07 per share. | 08 Jun 2022 | 10,000 | 6,854,880 (1%) | 0% | 148.1 | 1,480,700 | Common Stock |
| Moderna | Juan Andres | See remarks | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 08 Jun 2022 | 10,000 | 10,367 (0%) | 0% | 150 | 1,500,000 | Common Stock |
| Protara Therapeutics Inc | Gregory P. Sargen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Luke M. Beshar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Roger J. Garceau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Richard S. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Cynthia Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Barry P. Flannelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jane Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.